This is the most likely the important part of the
Post# of 148106
The drug more likely will be used for all the patients on vents or maybe the very cusp . That’s the number of the really needed product that most likely will be put to use in any country. For Philippines that number maybe 25,000 or so for sales . Ok your realistic number. ?? India much more but won’t venture a guess now .
“”We believe there is an immediate need for leronlimab in our country, to save COVID-19 infected patients who are on ventilators. We need to bring this product to market ASAP for them!”